Stargardt, Best disease and retinal electrophysiology

Stargardt Disease & Fundus Flavimaculatus

Stargardt disease is the most common hereditary juvenile macular dystrophy, with a prevalence of approximately 1 in 8,000 to 10,000 individuals. It is inherited almost exclusively as an autosomal recessive trait caused by bi-allelic pathogenic variants in the ABCA4 gene located on chromosome 1p22. When the condition manifests with widespread flecks extending into the mid-periphery in adult life, it is historically designated fundus flavimaculatus.

The ABCA4 Biochemical Cascade and A2E Lipofuscin Toxicity

The ABCA4 gene encodes an ATP-binding cassette transporter (historically termed the "rim protein") localized specifically to the outer segment disc margins of both rod and cone photoreceptors:

1. The Normal Visual Cycle Flippase: Upon photostimulation, rhodopsin photoisomerizes 11-cis-retinal into all-trans-retinal. Free all-trans-retinal reacts with phosphatidylethanolamine (PE) inside the disc lumen to form N-retinylidene-phosphatidylethanolamine (N-ret-PE). ABCA4 acts as an ATP-dependent flippase, actively transporting N-ret-PE across the disc membrane from the luminal leaflet to the cytoplasmic leaflet. In the cytoplasm, all-trans-retinal dissociates and is reduced to all-trans-retinol by retinol dehydrogenase.
2. Flippase Failure & A2E Synthesis: In ABCA4 deficiency, N-ret-PE is trapped within the disc lumen. Trapped N-ret-PE non-enzymatically condenses with a second molecule of all-trans-retinal to generate A2E (pyridinium bisretinoid) and related toxic bisretinoid fluorophores.
3. Lysosomal RPE Poisoning: When photoreceptor outer segments are routinely shed and phagocytosed by RPE cells, A2E cannot be degraded by lysosomal enzymes. A2E accumulates as toxic, fluorescent lipofuscin granules within RPE lysosomes. A2E exhibits detergent-like properties that permeabilize lysosomal membranes, impairs the RPE $\text{Na}^+/\text{K}^+$-ATPase pump, and releases reactive oxygen species upon blue light exposure ($400-480\,\text{nm}$), culminating in apoptotic RPE death followed by secondary photoreceptor atrophy.

Clinical Presentation & Multimodal Diagnostics

• Presentation: Bilateral, symmetric, progressive reduction in central distance and near visual acuity typically presenting between ages 8 and 15 years (often dropping to $6/60$ [$20/200$]), frequently accompanied by central scotomas and dyschromatopsia. In early stages, visual acuity loss is characteristically disproportionate to the subtle macular changes, often leading to erroneous suspicions of non-organic (functional) visual loss.
• Macular Appearance: Early loss of the foveal reflex evolves into a granular, "snail-slime" or oval "beaten-bronze" appearance of central RPE atrophy, progressing to well-circumscribed geographic foveal atrophy.
• Pisciform Flecks: Yellowish-white, fish-tail-shaped (pisciform) or triradiate lesions situated at the level of the RPE. Flecks undergo a dynamic lifecycle: active flecks appear intensely hyperautofluorescent, then gradually fade over years to leave round, hypoautofluorescent atrophic scars.
• Diagnostic Multimodal Imaging:
  • Fundus Autofluorescence (FAF): The single most sensitive and characteristic diagnostic investigation! Active pisciform flecks exhibit intense hyperautofluorescence (representing A2E lipofuscin accumulation within stressed RPE cells). In the fovea, RPE cell death creates a sharply demarcated, round or oval zone of profound hypofluorescence (a jet-black patch of macular atrophy).
  • Fluorescein Angiography (FA): Displays the characteristic "dark choroid" (or "silent choroid"), present in approximately 85% of Stargardt patients. The massive accumulation of lipofuscin throughout the entire RPE monolayer strongly absorbs the blue excitation wavelengths ($465-490\,\text{nm}$), blocking underlying choroidal fluorescence during the early transit phase. Retinal vessels stand out in sharp contrast against a completely black, non-fluorescent choroid. In the macula, central RPE atrophy produces a bright transmission window defect.
  • SD-OCT: Demonstrates early loss of the foveal ellipsoid zone (EZ band) and external limiting membrane, thinning of the outer nuclear layer, and late complete excavation of the foveal RPE and neurosensory retina.
• Counselling: Avoid unnecessary high-dose vitamin A supplements in ABCA4 disease, while maintaining normal nutrition and treating proven deficiencies appropriately. UV protection and rehabilitation can help; special blue-blocking lenses are not a proven cure or progression guarantee.

Best Vitelliform Macular Dystrophy (Best Disease)

Best disease (vitelliform macular dystrophy) is an autosomal dominant condition with variable penetrance and expressivity, caused by heterozygous pathogenic variants in the BEST1 gene located on chromosome 11q12.

Molecular Genetics & Pathogenesis

The BEST1 gene encodes bestrophin-1, a homopentameric transmembrane calcium-activated chloride channel localized exclusively to the basolateral plasma membrane of the retinal pigment epithelium. Dysfunctional bestrophin-1 disrupts chloride and fluid conductance across the basolateral RPE membrane, uncoupling normal fluid resorption from the subretinal space. As a consequence, unphagocytosed photoreceptor outer segment debris, lipofuscin fluorophores, and fluid accumulate abnormally between the apical microvilli of the RPE and the photoreceptor outer segments.

The Five Clinical Stages of Best Disease

1. Stage 1 (Pre-Vitelliform): Normal funduscopy or subtle, tiny yellow foveal punctate dots in an asymptomatic child or infant. Visual acuity is entirely normal ($6/6$ / $20/20$). Crucially, the electro-oculogram (EOG) is already severely subnormal.
2. Stage 2 (Vitelliform): Characterized by a sharply circumscribed, elevated, round, dome-shaped, bright yellow-orange subretinal lesion (typically 1 to 2 disc diameters in size) centered precisely on the fovea, mimicking an "egg-yolk" (sunny-side up). Usually presents between ages 3 and 15 years. Paradoxically, best-corrected visual acuity is remarkably well preserved (typically $6/6$ to $6/12$ / $20/20$ to $20/40$), despite the striking anatomical lesion.
3. Stage 3 (Pseudohypopyon): The yellow vitelliform material partially liquefies, settling gravitationally into the dependent, inferior half of the subretinal cavity to create a horizontal fluid line mimicking a hypopyon. Often observed in adolescents when changing posture. Visual acuity remains relatively stable.
4. Stage 4 (Vitelliruptive / "Scrambled Egg"): The vitelliform blister ruptures, fragmenting into an irregular, heterogeneous constellation of scrambled yellow debris, pigmented clumping, and localized fluid. Visual acuity begins to decline significantly ($6/18$ to $6/36$).
5. Stage 5 (Atrophic / Cicatricial): The vitelliform material is completely resorbed, leaving a central patch of geographic RPE and photoreceptor atrophy. In approximately 20% of eyes, this stage is complicated by secondary subretinal choroidal neovascularisation (CNV), producing a fibrous disciform scar with visual acuity dropping to $\le 6/60$ ($20/200$). Secondary CNV responds favourably to intravitreal anti-VEGF therapy.

The Diagnostic Hallmark: EOG vs. ERG

The definitive diagnostic hallmark of Best disease—and a premier testing point on the EBOD—is the striking dissociation between the electro-oculogram and the full-field electroretinogram:

• The Electro-oculogram (EOG): characteristically usually subnormal, but sometimes normal in genetically confirmed disease (as well as in asymptomatic, gene-positive carriers). The Arden ratio is severely attenuated: $\text{Arden Ratio} = \frac{\text{Light Peak Amplitude}}{\text{Dark Trough Amplitude}} < 1.5 \quad (\text{Normal: } > 1.85 \text{ to } 2.0)$
• Full-Field Electroretinogram (ffERG): Completely NORMAL across all scotopic and photopic flash responses. Because the bestrophin-1 defect is restricted to basolateral RPE chloride transport, mass photoreceptor and bipolar electrical activity across the wider retina remains intact.

Retinal Electrophysiology: ISCEV Standards

The International Society for Clinical Electrophysiology of Vision (ISCEV) has standardized the administration and reporting of visual electrophysiology:

1. Full-Field Electroretinogram

The full-field ERG measures summed retinal responses and can be abnormal with preserved macular acuity. ISCEV 2022 specifies six standard responses: dark-adapted 0.01, 3 and 10 ERGs; dark-adapted 3 or 10 oscillatory potentials; light-adapted 3 ERG; and light-adapted 30-Hz flicker. Standard dark adaptation is at least 20 minutes and light adaptation at least 10 minutes. The weak dark-adapted response mainly assesses the rod pathway; strong dark-adapted flashes assess mixed rod/cone pathways, and photopic responses assess cone pathways. The a-wave predominantly reflects photoreceptors and the b-wave post-receptoral activity, particularly bipolar cells. An electronegative response has a disproportionately small b-wave and suggests post-receptoral dysfunction, but is not one disease diagnosis.

2. Pattern Electroretinogram (PERG) & Visual Evoked Potential (VEP)

• Pattern ERG (PERG): Elicited by an alternating high-contrast black-and-white checkerboard stimulus centered on the fovea, evaluating localized macular and ganglion cell function:
  • P50 Wave: Prominent positive deflection occurring at ~50 ms, reflecting macular function with substantial ganglion-cell contribution.
  • N95 Wave: Negative deflection occurring at ~95 ms, generated selectively by retinal ganglion cells; attenuated in optic neuropathies and glaucoma, although P50 can also be affected depending on disease severity.
• Visual Evoked Potential (VEP): Records cortical electrical potentials generated at the primary visual cortex (V1) over the occipital pole (Oz electrode) in response to visual stimuli:
  • Pattern-Reversal VEP: Standard modality assessing the integrity of the anterior visual pathways. Measures the P100 wave (major positive peak occurring at $\approx 100\,\text{ms}$):
    • P100 interpretation: Pattern VEP assesses the pathway from retina to visual cortex. Compare laboratory age- and stimulus-specific reference values, interocular differences, waveform and technical quality; a single universal latency cutoff does not establish demyelination.
    • P100 interpretation: Pattern VEP assesses the pathway from retina to visual cortex. Compare laboratory age- and stimulus-specific reference values, interocular differences, waveform and technical quality; a single universal latency cutoff does not establish demyelination.